A recent economic evaluation published in the Indian Journal of Medical Research has concluded that a six-month all-oral treatment regimen for multidrug-resistant and rifampicin-resistant tuberculosis (MDR/RR-TB) is both cost-effective and capable of improving health outcomes compared...
New Delhi, India: FUJIFILM India, a leading imaging company, flags off their recent CSR Campaign for Tuberculosis Screening in Valsad, Gujarat with a commitment to strengthen the government’s effort of “TB Harega Desh Jeetega”. Spanning over...
India has been battling tuberculosis for decades, with the disease claiming thousands of lives every year. Despite government efforts that have certainly yielded remarkable...
In continuation of its commitment to make India TB free, Mission TB free Haryana, a flagship initiative of Medanta in collaboration with the International Union...
Ahead of the first-ever United Nations (UN) High-Level Meeting on Tuberculosis (TB), Johnson & Johnson announced a comprehensive 10-year initiative in support of the...
The World Health Organization’s (WHO) Global Tuberculosis Report 2017 revealed that an estimated 10.4 million people fell ill with TB in 2016: 56% of...
